Streamline Health So (STRM) 1.44 $STRM Streamline

New Post Public Reply Private Reply Replies (0) Message Board

Sep 4, 2016 at 7:10 AM

Streamline Health So (STRM) 1.44 $STRM

Streamline Health® to Report Second Quarter 2016 Financial Performance on September 7, 2016
PR Newswire - Wed Aug 31, 8:00AM CDT
Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the Looking Glass® platform of integrated solutions and analytics supporting revenue cycle optimization for healthcare enterprises in the new value-based world, today announced that it will release its second quarter 2016 financial performance for the period that ended July 31, 2016, on Wednesday, September 7, 2016.
STRM: 1.44 (-0.05)

Cerner (CERN) Beats Q2 Earnings, Revises '16 Revenue View
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 1:49PM CDT
Cerner Corp (CERN) reported adjusted earnings of 54 cents per share, which beat the Zacks Consensus Estimate by a penny.
ABCO: 42.22 (+0.04), STRM: 1.44 (-0.05), AHS: 36.25 (+0.57), CERN: 64.77 (-0.24)

Streamline Health® Reports First Quarter 2016 Revenues of $6.7 Million; Adjusted EBITDA of $0.6 Million; $1.5 Million Net Loss
PR Newswire - Wed Jun 08, 3:01PM CDT
Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the Looking Glass® platform of integrated solutions and analytics supporting revenue cycle optimization for healthcare enterprises in the new value-based world, today announced financial results for the first quarter of fiscal 2016, which ended April 30, 2016.
STRM: 1.44 (-0.05)

Streamline Health® To Report First Quarter 2016 Financial Performance On June 8, 2016
PR Newswire - Tue May 31, 8:00AM CDT
Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the Looking Glass® platform of integrated solutions and analytics supporting revenue cycle optimization for healthcare enterprises in the new value-based world, today announced that it will release its first quarter 2016 financial performance for the period that ended April 30, 2016, on Wednesday, June 8, 2016.
STRM: 1.44 (-0.05)

Streamline Health® Reports Fourth Quarter And Fiscal Year 2015 Financial Performance
PR Newswire - Wed Apr 20, 4:00PM CDT
Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the Looking Glass® platform of integrated solutions and analytics supporting revenue cycle optimization for healthcare enterprises in the new value-based world, today announced financial results for the fourth quarter and fiscal year of 2015, which ended January 31, 2016.
STRM: 1.44 (-0.05)

Streamline Health® To Report Fourth Quarter And Fiscal Year 2015 Financial Performance
PR Newswire - Wed Apr 13, 8:45AM CDT
Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the Looking Glass® platform of integrated solutions and analytics supporting revenue cycle optimization for healthcare enterprises in the new value-based world, today announced that it will release its fourth quarter and fiscal year 2015 financial performance for the period that ended January 31, 2016, on Wednesday, April 20, 2016.
STRM: 1.44 (-0.05)

Streamline Health® Appoints Shaun Priest In Newly Created Position Of Chief Growth Officer
PR Newswire - Mon Apr 11, 8:00AM CDT
Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the Looking Glass® platform of integrated solutions and analytics supporting revenue cycle optimization for healthcare enterprises in the new value-based world, today announced the appointment of Mr. Shaun Priest as Senior Vice President and Chief Growth Officer, effective April 6, 2016. Mr. Priest will report directly to David Sides, President and Chief Executive Officer, Streamline Health.
STRM: 1.44 (-0.05)

athenahealth Crushes Q4 Earnings Estimate, Revenues Meet
Zacks Equity Research - Zacks Investment Research - Fri Feb 05, 10:30AM CST
athenahealth Inc. (ATHN) reported earnings of 45 cents per share in the fourth quarter of 2015, well ahead of the Zacks Consensus Estimate of 16 cents.
STRM: 1.44 (-0.05), CPSI: 25.38 (-0.14), OMCL: 38.88 (+0.58), ATHN: 123.61 (+0.48)

Edwards Lifesciences (EW) Likely to Top Earnings Again in Q4
Zacks Equity Research - Zacks Investment Research - Fri Jan 29, 12:31PM CST
Last quarter, Edwards Lifesciences (EW) had delivered a positive earnings surprise of 10.20%.
GILD: 76.89 (-0.53), ADHD: 4.77 (+0.03), EW: 115.85 (-0.02), STRM: 1.44 (-0.05)

Streamline Health's Enterprise Scheduling And Resource Management Solution Named 2015/2016 Category Leader In Best In KLAS®
PR Newswire - Thu Jan 28, 8:16AM CST
Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of transformational data-driven solutions to help healthcare providers reduce exposure to risk, enhance clinical, financial, and operational performance, and improve patient care, today announced that its Looking Glass® Enterprise Scheduling and Resource Management solution was named Category Leader in the 2015/2016 Best in KLAS report published earlier today by KLAS. This makes 13 years in a row that it has been the highest ranked solution in its category.
STRM: 1.44 (-0.05)

Will Myriad Genetics Q2 Earnings (MYGN) Surprise Investors?
Zacks Equity Research - Zacks Investment Research - Wed Jan 27, 12:55PM CST
Last quarter, Myriad Genetics (MYGN) had delivered a positive earnings surprise of 17.14%
MYGN: 20.65 (+0.21), GILD: 76.89 (-0.53), STRM: 1.44 (-0.05), ARAY: 5.42 (+0.12)

Will Thermo Fisher (TMO) Surprise Q4 Earnings Expectations?
Zacks Equity Research - Zacks Investment Research - Tue Jan 26, 11:40AM CST
Thermo Fisher Scientific, Inc. (TMO) is slated to report its fourth-quarter 2015 earnings numbers before the opening bell on Jan 28.
GILD: 76.89 (-0.53), TMO: 151.18 (+0.23), STRM: 1.44 (-0.05), ARAY: 5.42 (+0.12)

Why Q4 Earnings Beat is Dicey at Quest Diagnostics (DGX)
Zacks Equity Research - Zacks Investment Research - Mon Jan 25, 1:05PM CST
Quest Diagnostics Inc. (DGX) is scheduled to report its fourth-quarter 2015 earnings results before the opening bell on Jan 28, 2016.
GILD: 76.89 (-0.53), DGX: 83.04 (+0.68), STRM: 1.44 (-0.05), ARAY: 5.42 (+0.12)

Medidata: Clinical Cloud Uptake & Client Base on the Rise
Zacks Equity Research - Zacks Investment Research - Thu Jan 21, 12:20PM CST
Medidata Solutions (MDSO) continues to win clients for its Sunrise platform.
MDSO: 54.85 (+1.12), STRM: 1.44 (-0.05), OMCL: 38.88 (+0.58), ATHN: 123.61 (+0.48)

Allscripts' (MDRX) Sunrise EHR Demand Continues to Rise
Zacks Equity Research - Zacks Investment Research - Thu Jan 21, 10:50AM CST
Allscripts Healthcare Solutions (MDRX) recently announced that its Sunrise platform has been selected as an Electronic Health Record system by Tuba City Regional Health Care Corporation.
STRM: 1.44 (-0.05), MDRX: 12.88 (-0.03), OMCL: 38.88 (+0.58), ATHN: 123.61 (+0.48)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of Streamline Health Solutions, Inc. -- STRM
PR Newswire - Thu Jan 14, 11:34AM CST
Levi & Korsinsky announces it has commenced an investigation of Streamline Health Solutions, Inc. (NASDAQCM: STRM) concerning possible breaches of fiduciary duty by the board of directors of the company. To obtain additional information, go to:
STRM: 1.44 (-0.05)

Allscripts Q4 Bookings Likely to Hit Record Levels, Stock Up
Zacks Equity Research - Zacks Investment Research - Wed Jan 13, 12:00PM CST
Allscripts (MDRX) expects fourth-quarter bookings to cross the all-time high of $327 million recorded in fourth-quarter 2011.
STRM: 1.44 (-0.05), MDRX: 12.88 (-0.03), OMCL: 38.88 (+0.58), ATHN: 123.61 (+0.48)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

JOYEE N01 Debuts Globally with First 2,000 Deliveries

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

EFICYENT Ventures to Connect at Singapore FinTech Fest

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Webull Faces Class Action: Key Details for Investors

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Layne's Chicken Fingers Expands with Brownsville Opening

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

YSTUDIO's Pens: A Nod to the Power of Writing

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

WHO and RCSI Bahrain Join Forces on Health Initiatives

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Novo's CagriSema Trials Show Promising Weight Loss

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...